PURE Bioscience Ships Initial Order to Italian Export Consortium, TICE

PURE Bioscience Ships Initial Order to Italian Export Consortium, TICE 
PURE Products Now REACH Pre-Registered, Authorizing TICE to Import
and Distribute PURE Products Across Europe 
SAN DIEGO, CA -- (Marketwired) -- 06/07/13 --  PURE Bioscience, Inc.
(OTCQB: PURE), the creator of the patented silver dihydrogen citrate
(SDC) antimicrobial, shipped an opening order of PURE Hard Surface
and PURE Multi-Purpose Cleaner Concentrate to European distributor
and Italian export consortium, TICE.  
"We have placed this order as part of our initial campaign of
customer trials and evaluation," said Dosolino Marangon, president of
TICE. "We have been receiving a positive response to our education
and marketing campaigns for PURE products, and anticipate a
successful product launch in Italy followed by introductions in more
than 25 additional European countries." 
Since PURE announced its partnership with TICE in September 2012,
TICE has been pursuing the necessary REACH requirements to distribute
PURE's disinfecting and cleaning products in the European Union.
REACH, which stands for registration, evaluation, authorization and
restriction of chemicals, represents the European Community's
regulation on chemicals and their safe use. REACH also mandates the
progressive substitution of the most dangerous chemicals when
suitable alternatives have been identified. TICE has filed the REACH
pre-registration of PURE Hard Surface, PURE Multi-Purpose cleaner
concentrate and PURE Floor Cleaner with the European Chemical Agency
(ECHA), authorizing TICE by European law to import and distribute
PURE Products throughout Europe. 
"This shipment and the REACH filing are milestone events for our
company," said Michael L. Krall, PURE Bioscience's president and CEO.
"We appreciate the time, resources and investment TICE has committed
to gain regulatory clearance for distribution of PURE products in
Italy and elsewhere in Europe. We look forward to this first
commercial launch of PURE across Europe." 
About TICE
 TICE (The Italian Consortium Export) is a consortium
composed of Italian companies who have as their main philosophy the
promotion and sale of 100% made-in-Italy products, with an emphasis
on the North American market. The product categories for TICE
marketing include food and wine, production and process systems,
renewable energy process systems, hospitality and restaurant
decoration and design. Started on an experimental level in 2002, the
TICE Consortium was officially founded in 2004 with a small number of
companies. Over the years this number has grown, which has allowed
TICE to create a network of business relationships in Italy, the
United States and Mexico to execute innovative business concepts. For
more information about TICE, visit www.tice.it.  
About PURE Bioscience, Inc.
 PURE Bioscience, Inc. develops and
markets technology-based bioscience products that provide solutions
to numerous global health challenges, including Staph (MRSA) and
Carbapenem-resistant Enterobacteriaceae (CRE)/NDM-1+. PURE's
proprietary high efficacy/low toxicity bioscience technologies,
including its silver dihydrogen citrate-based antimicrobials,
represent innovative advances in diverse markets and lead today's
global trend toward industry and consumer use of "green" products
while providing competitive advantages in efficacy and safety.
Patented SDC is an electrolytically generated source of stabilized
ionic silver, which formulates well with other compounds. As a
platform technology, SDC is distinguished from competitors in the
marketplace because of its superior efficacy, reduced toxicity and
the inability of bacteria to form a resistance to it. PURE is
headquartered in El Cajon, California (San Diego metropolitan area).
Additional information on PURE is available at www.purebio.com.  
About PURE Hard Surface
 US EPA registered PURE Hard Surface
disinfectant and food contact surface sanitizer provides an
unparalleled combination of high efficacy and low toxicity with
30-second bacterial and viral kill times and 24-hour residual
protection. SDC-based PURE Hard Surface completely kills resistant
pathogens like MRSA and Carbapenem-resistant Klebsiella pneumoniae
(NDM-1) and also effectively eliminates dangerous fungi and viruses
including HIV, Hepatitis B, Hepatitis C, Norovirus, Influenza A,
Avian Influenza and H1N1 as well as hazardous food pathogens such as
E. coli, Salmonella and Campylobacter. PURE Hard Surface delivers
powerful broad-spectrum efficacy while remaining classified as
least-toxic (Category IV) by the US EPA, and its active ingredient,
SDC, has been determined Generally Recognized as Safe (GRAS) for use
as a biocide on food processing equipment, machinery and utensils. 
About PURE Floor Cleaner and Multi-Purpose Concentrates
non-toxic, environmentally responsible cleaning products are
protected by SDC, a natural, non-toxic antimicrobial. SDC ensures the
quality and safety of PURE Floor Cleaner and PURE Multi-Purpose
Cleaner without human or environmental exposure to toxic chemical
preservatives. PURE Floor Cleaner and PURE Multi-Purpose cleaner are
non-flammable and contain no EDTA, phosphates, ammonia or bleach as
well as no VOCs or NPEs. PURE Floor Cleaner and PURE Multi-Purpose
Cleaner provide professional strength cleaning in a concentrate
formula that yields a 1:128 use dilution that is safe for use on all
resilient surfaces. The active ingredients in the cleaner products
meet the US EPA's DfE (Design for the Environment) Criteria for Safer
Chemical Ingredients. 
Forward-looking Statements
 This press release includes statements
that may constitute "forward-looking" statements, usually containing
the words "believe," "estimate," "expect," "intend," "project" or
similar expressions. These statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of
1995. Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. Factors that would cause or
contribute to such differences include, but are not limited to, the
Company's cash position and liquidity requirements, the Company's
failure to implement or otherwise achieve the benefits of its
proposed initiatives and business plans, acceptance of the Company's
current and future products and services in the marketplace, the
ability of the Company to develop effective new products and receive
regulatory approvals of such products, competitive factors,
dependence upon third-party vendors, and other risks detailed in the
Company's periodic report filings with the Securities and Exchange
Commission. By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions or
changes after the date of this release. 
Investor Relations Contact:
Ron Both
Liolios Group, Inc.
Tel 949-574-3860
Press spacebar to pause and continue. Press esc to stop.